Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Clement Gakuba
Preclinical Evidence Toward the Use of Ketamine for Recombinant Tissue-Type Plasminogen Activator-Mediated Thrombolysis Under Anesthesia or Sedation
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Related publications
Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.
Journal of Pharmacobio-Dynamics
Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator
Surgery for Cerebral Stroke
Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Thrombolysis With Intravenous Recombinant Tissue Plasminogen Activator During Early Postpartum Period: A Review of the Literature
Acta Obstetricia et Gynecologica Scandinavica
Medicine
Gynecology
Obstetrics
Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
The Tissue-Type Plasminogen Activator Story
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients Over 80 Years Old: The Fukuoka Stroke Registry
PLoS ONE
Multidisciplinary
Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).
The Japanese Journal of Pharmacology
